Drug-drug interactions affecting drug levels of direct oral anticoagulants in the real world: A systematic review
Background: Direct oral anticoagulants (DOACs) have emerged as safe and effective alternatives to Vitamin-K antagonists for treatment and prevention of arterial and venous thrombosis. Due to their novelty, pharmacokinetic DOAC drug-drug interactions (DDIs) that result in clinical adverse events have...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12503
- Acceso en línea:
- https://doi.org/10.1016/j.thromres.2020.08.016
http://hdl.handle.net/20.500.12010/12503
- Palabra clave:
- Direct oral anticoagulant
Drug interaction
Bleeding
Thrombosis
Thromboembolism
Adverse event
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Acceso restringido